Hematology Oncology Associates, SJ, PA

Mount Holly, New Jersey 08060

0 studies enrolling now · 5 studies all time

What they study most

Carcinoma, Non-Small-Cell Lung, Colorectal Cancer, Lung Cancer, Neoplasms, Lung, Neoplasms, Pulmonary, Non-Small Cell Lung Cancer, Prostate Cancer, Small Cell Lung Cancer

Studies at this site

• FOLFIRI Alone Versus FOLFIRI Plus Bevacizumab Versus FOLFIRI Plus E7820 as Second-Line Therapy in Patients With Locally Advanced or Metastatic Colorectal Cancer — Stopped early
• Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer — Completed
• Pemetrexed as Second-Line Therapy in Treating Patients With Hormone Refractory Prostate Cancer — Completed
• Pemetrexed and Radiation for Poor-Risk Stage III Non-Small Cell Lung Cancer — Stopped early
• Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy — Stopped early